Scientific Research News

News about theoretical and practical scientific research spanning a wide variety of disciplines, including engineering, computer science, biology, physics and chemistry. Includes information about research facilities, funding, resources and public policy.

MPFI Researcher Receives Prominent Award to Launch New Lab

MPFI Researcher Receives Prominent Award to Launch New Lab

The Max Planck Florida Institute for Neuroscience announces that Dr. Madineh Sarvestani has been named a Freeman Hrabowski Scholar by the Howard Hughes Medical Institute. The award provides up to $8.6 million for five to 10 years to support outstanding early-career faculty members who have strong potential to become leaders in the field and who are committed to advancing diversity, equity, and inclusion in science through their mentorship of trainees from populations underrepresented in science. - May 09, 2023 - Max Planck Florida Institute for Neuroscience

150 Next-Generation Bionic Arm Prostheses from CF Dopomogator Founded by Olena Chernovolova

150 Next-Generation Bionic Arm Prostheses from CF Dopomogator Founded by Olena Chernovolova

Charity foundation Dopomogator (founded by Olena Chernovolova) and Allbionics.io team have announced the launch of a bionic prosthetics project for Ukrainians who have lost limbs during the war. According to the founder of the Found, Olena Chernovolova, the goal of the project is to return adults and children who have become victims of the war to a full life. - May 05, 2023 - Dopomogator

Northern College and the Canadian College of Naturopathic Medicine Announce Collaboration

Memorandum of Understanding underscores current need to increase access for health care learners and develop health care resources in northern communities - May 03, 2023 - Canadian College of Naturopathic Medicine

Cyclists Ride Through MA, NH, and ME in Tri-State Trek to Benefit ALS Research

Cyclists Ride Through MA, NH, and ME in Tri-State Trek to Benefit ALS Research

June 24-25, cyclists of all levels are invited to participate in the Tri-State Trek, a New England cycling event raising funds for cutting-edge research to end ALS. - May 03, 2023 - ALS Therapy Development Institute

New Traceable Opioid Material® Kit Expands Coverage to Other Emerging Drugs of Concern in Seized Samples and Toxicological Casework

Cayman Chemical and the Centers for Disease Control and Prevention (CDC) have released a new addition to the Traceable Opioid Material® Kits (TOM Kits®) product line that expands testing laboratory capabilities beyond synthetic opioids to include additional emerging drugs of abuse that are commonly found as co-drugs in fentanyl-containing samples. - April 30, 2023 - Cayman Chemical Company

Recent Findings on Perceived Out-of-Body Experiences Raise New Scientific Questions

All of these findings not only add to the current literature on OBEs and near-death experiences, but also point out important dilemmas and raise some new questions. - April 30, 2023 - The NDE OBE Research Project

Creative Diagnostics Introduces Virus Yield Reduction Assay Service

Creative Diagnostics introduced the Virus Yield Reduction Assay Service to support researchers in evaluating the antiviral activity of compounds. - April 29, 2023 - Creative Diagnostics

NanoCellect Biomedical Announces New Distribution Partnerships in Asia and Europe

NanoCellect Biomedical Announces New Distribution Partnerships in Asia and Europe

NanoCellect Biomedical, the leading provider of microfluidic flow cytometry platforms, has announced new distributor partnerships in Asia and Europe to expand its global reach and provide greater accessibility to its innovative technologies. - April 26, 2023 - NanoCellect Biomedical

Code Tenderloin New Partnership/Internship with Renegade.Bio and Tougaloo College

Code Tenderloin New Partnership/Internship with Renegade.Bio and Tougaloo College

Code Tenderloin is a non-profit that provides dignity and opportunity through intense job readiness and workforce development program serving those in need. Through barrier removal, we can serve those in life transitions with jobs, education, training, and connections to our referral network of housing, health, reentry programs, and child care services. - April 18, 2023 - Code Tenderloin

Thermo Fisher Partners with ALPCO-GeneProof to Broaden Their CE-IVD Molecular Assay Portfolio

ALPCO-GeneProof, a global leader in diagnostics, and Thermo Fisher announced a strategic partnership that brings the TaqPath Menu | GeneProof PCR kits to market. The partnership combines the strengths of ALPCO-GeneProof’s expertise in molecular diagnostics with Thermo Fisher’s robust... - April 17, 2023 - ALPCO

ProMedix Inc. Awarded Competitive Grant from the U.S. National Science Foundation

ProMedix Inc. Awarded Competitive Grant from the U.S. National Science Foundation

ProMedix Inc. has been awarded a U.S. National Science Foundation (NSF) Small Business Technology Transfer (STTR) grant for $250,000.00 to conduct research and development (R&D) work on improving outcomes from sepsis through active digital monitoring of peripheral blood flow. Impaired... - April 17, 2023 - ProMedix Inc.

Plan to Use Wild Horses for Wildfire Fuel Mitigation Characterized as "Innovative Approach" by AM Best TV

Plan to Use Wild Horses for Wildfire Fuel Mitigation Characterized as "Innovative Approach" by AM Best TV

California nonprofit's nature-based wildfire solution recently garnered the attention of AM Best TV, which provides mission critical information to Insurance companies. - April 12, 2023 - Wildhorse Ranch Productions

Black Students in Pittsburgh 3-D Print Living Artery as Part of C-3PO Project

In the C-3PO project of The Citizen Science Lab, African American high school and middle school students have 3-D printed their first living body part. - April 12, 2023 - The Citizen Science Lab

Trent University and Canadian College of Naturopathic Medicine Partner to Create New Pathways to Careers in Holistic Healthcare

Memorandum of Understanding Establishes Partnership for Innovative Research and Program Collaboration - April 11, 2023 - Canadian College of Naturopathic Medicine

Expanded Analytical Chemistry Lab at Covalent Provides Comprehensive Testing for Solids and Liquids

A new ICP-OES and microwave digestor at Covalent Metrology round out its chemistry laboratory to deliver complete, modern chemical analysis for solid and liquid samples. - April 06, 2023 - Covalent Metrology

HSG and HD-CAB Collaborate to Provide Global Patient Advisory Board

HSG and HD-CAB Collaborate to Provide Global Patient Advisory Board

The Huntington Study Group (HSG) together with its wholly owned subsidiary, HSG Clinical Research, Inc., a world leader in conducting clinical trials for Huntington’s disease (HD), recently collaborated with Huntington’s Disease – Community Advisory Board (HD-CAB) to provide a... - March 30, 2023 - Huntington Study Group

New Research on Decentralized Clinical Trial (DCT) Strategies to Boost Patient Diversity

Current and Future Clinical Trial Participants Link Enhanced Diversity and Inclusion of Underrepresented Patient Populations to DCT - March 29, 2023 - Life Science Strategy Group, LLC

HSG Announces 30th Annual Meeting

HSG Announces 30th Annual Meeting

The Huntington Study Group (HSG), a world leader in conducting clinical trials and providing educational programming for Huntington’s disease (HD), recently announced that their 2023 Annual Meeting will be held November 2-4, 2023 at the Sheraton Grand at Wild Horse Pass in Chandler, AZ, a... - March 21, 2023 - Huntington Study Group

Diversity in Clinical Trials Summit 2023

Diversity in Clinical Trials Summit 2023

Upcoming Diversity in Clinical Trials Summit Aims to Address Disparities and Improve Patient Outcomes. - March 20, 2023 - Sonar Clinical Research

New Book from Oaklea Offers a Solution to the Scourge of Racism

New Book from Oaklea Offers a Solution to the Scourge of Racism

A new book just released by The Oaklea Press presents a case that racism is endemic in America due to erroneous beliefs prevalent in the national psyche perpetuated by outdated nineteenth century scientific theories still taught in schools, and that it can be cured by propagating the truth. - March 20, 2023 - The Oaklea Press

Gallant Deepens Its Bench by Adding Dr. Valentine Williams as Senior Vice President of Clinical Development and Regulatory

Gallant Deepens Its Bench by Adding Dr. Valentine Williams as Senior Vice President of Clinical Development and Regulatory

Furthering its mission to bring regenerative medicine to all pets, animal biotech company Gallant Therapeutics welcomes an industry leader, Dr. Val Williams, to its pioneering team. - March 17, 2023 - Gallant

Breaking Barriers: ALS TDI Unveils Groundbreaking ALS Research Collaborative (ARC) to Accelerate Global Research in ALS

Breaking Barriers: ALS TDI Unveils Groundbreaking ALS Research Collaborative (ARC) to Accelerate Global Research in ALS

The ALS Research Collaborative will revolutionize ALS research by providing scientists with unprecedented access to the data and tools they need to discover new treatments and accelerate progress toward cures for ALS. - March 15, 2023 - ALS Therapy Development Institute

New Research Identifies Latest Clinical Development and CRO Outsourcing Trends in China

Groundbreaking Research Explores the Chinese Innovative Biopharmaceutical Clinical Development Market, CRO Outsourcing and Future Growth with Over 100 Chinese Biopharma Professionals - March 15, 2023 - Life Science Strategy Group, LLC

New Tax Law Could Destroy Innovative Small Businesses and Block Innovation

Over 500 CEOs and Small Business Leaders Sign Letter to Congress Urging Immediate Action to Protect US Innovation - March 14, 2023 - Eva Garland Consulting

Creative Diagnostics Introduces Microneutralization Assay Service for Virus Detection

Creative Diagnostics recently introduced the Microneutralization Assay Service to support research labs in detecting virus-specific neutralizing antibodies from human and animal sera. - March 12, 2023 - Creative Diagnostics

Creative Diagnostics Introduces TCID50 Assay Service for Determining Viral Titers

Creative Diagnostics recently introduced the TCID50 Assay Service suitable for drug sensitivity tests, infectious units quantification, the determination of virus doses, as well as virus release studies. - February 17, 2023 - Creative Diagnostics

The Retreat Announces the Curtis Carlson Nelson Research Institute to Focus on Addiction and Recovery Research, Advocacy

The Retreat Announces the Curtis Carlson Nelson Research Institute to Focus on Addiction and Recovery Research, Advocacy

The Retreat is announcing The Curtis Carlson Nelson Research Institute at The Retreat. Created to honor the legacy of longtime friend Curtis Carlson Nelson, it will focus on research and advocacy into substance abuse and recovery. The first project will study outcomes for Twelve Step, abstinence- and community-based recovery models. The research will be conducted by Dr. John Kelly of Harvard Medical School, Massachusetts General Hospital and the Recovery Research Institute. - February 02, 2023 - The Retreat

The Area 51 First Contact Research Center Documents Improved Instrument Resolution Bandwidth & Sensitivity Settings for Advance Life Form Studies

The Area 51 First Contact Research Center investigators, using industry leading electromagnetic spectrum analyzers, determined -120 dBm as a new instrument sensitivity setting for working with sources of Area 51 Advanced Life Form evidence. The new instrument resolution bandwidth requirement was... - February 01, 2023 - Area 51 First Contact Research Center

New Book from The Oaklea Press Climbs to “Number One New Release” in Two-Hour Science and Math Short Reads

New Book from The Oaklea Press Climbs to “Number One New Release” in Two-Hour Science and Math Short Reads

“Proof Mind Creates Matter,” a book recently released that reports on quantum physics experiments and other research has topped the new release bestseller chart on Amazon for two-hour science and math reads. - January 23, 2023 - The Oaklea Press

The Canadian College of Naturopathic Medicine and Southern Cross University of Australia Announce Collaboration

International collaboration highlights reach and depth of naturopathic education around the world. The Canadian College of Naturopathic Medicine (CCNM) and the National Centre for Naturopathic Medicine at Southern Cross University (SCU), Australia have signed a memorandum of understanding (MOU)... - January 19, 2023 - Canadian College of Naturopathic Medicine

Huntington Study Group Names First Chief Innovation Officer

Huntington Study Group Names First Chief Innovation Officer

The Huntington Study Group (HSG), a world leader in clinical research for Huntington’s Disease (HD) for over 30 years, today announced Brett Kinsler has been named to the newly created position of Chief Innovation Officer (CINO). - January 10, 2023 - Huntington Study Group

Creative Diagnostics Introduces New Hemagglutination Inhibition Assay Services

Creative Diagnostics recently introduced Hemagglutination Inhibition Assay services to determine relative concentrations of viruses, bacteria, or antibodies. - January 06, 2023 - Creative Diagnostics

Creative Diagnostics Introduces Plaque Reduction Assay Service for Research Applications

Creative Diagnostics recently introduced Plaque Reduction Assay services to detect antibodies from testing serum and viruses within diseased materials to diagnose viral infectious diseases. - December 28, 2022 - Creative Diagnostics

PharmStars Announces Fall 2022 Accelerator Graduates: 11 Digital Health Startups Complete PharmStars’ Pharma-Focused Accelerator Program

PharmStars Announces Fall 2022 Accelerator Graduates: 11 Digital Health Startups Complete PharmStars’ Pharma-Focused Accelerator Program

PharmStars, the pharma-focused accelerator for digital health startups, announces the graduation of 11 startups from its Fall 2022 program focused on “Innovations in Real-World Evidence.” The graduating startups successfully completed PharmaU, PharmStars’ 10-week education, and mentoring program. PharmaU culminated with a Showcase Event--held in Boston in early November--that brought together the participating startups and PharmStars’ seven innovation-minded pharma members. - December 08, 2022 - PharmStars

PharmStars Announces “Innovations in Women’s Health and Health Equity” Theme for Spring 2023 Accelerator

PharmStars Announces “Innovations in Women’s Health and Health Equity” Theme for Spring 2023 Accelerator

PharmStars, the pharma-focused accelerator for digital health startups, is now accepting applications for its Spring 2023 cohort with the theme “Digital Innovations in Women’s Health and Health Equity.” Startups with digital innovations that promote more equitable, inclusive healthcare for underserved population or focused on women’s health (e.g., breast, ovarian, and cervical cancer; gynecological conditions; osteoporosis; menopausal, hormonal, and reproductive conditions) are welcome to apply. - December 05, 2022 - PharmStars

UserWise, LLC Launches Its First eLearning Catalog

UserWise, LLC Launches Its First eLearning Catalog

UserWise, LLC, a San Jose, California-based Human Factors consultancy, has launched UserWise University, another step towards helping develop safe and usable medical devices. - December 01, 2022 - UserWise, LLC

Creative Diagnostics Introduces Hemagglutination Assay Service for Scientific Applications

Creative Diagnostics recently introduced Hemagglutination Assay services for influenza vaccine, diagnostic, and surveillance communities to measure virus and antibody titers and monitor influenza subtypes. - November 26, 2022 - Creative Diagnostics

Resoptima Partners with Aker BP, Sval Energi, and NORCE to Reduce CO2 Emissions for Oil and Gas Production

Resoptima Partners with Aker BP, Sval Energi, and NORCE to Reduce CO2 Emissions for Oil and Gas Production

Resoptima announced today a joint project with the support of the Research Council of Norway. The partnership includes Aker BP and Sval Energi as E&P operators and NORCE as an independent research institute. The project aims at leveraging Resoptima’s reservoir modelling and reservoir management technologies to further develop specific solutions that will help reduce CO2 emissions associated with oil and gas asset development and production activities. - November 17, 2022 - Resoptima

Are You Ready to Get Shroomed?

Are You Ready to Get Shroomed?

After a historical win for the war on drugs in Colorado, the state and the nation begins to look at ways to implement Magic Mushroom assisted therapy along with other plant medicine. We look at the facts behind this, and what it means for you. - November 11, 2022 - shroomed

DataJoint Launches New Cloud-Based System for Automating Neuroscience Experiments

DataJoint Launches New Cloud-Based System for Automating Neuroscience Experiments

DataJoint's New Cloud Solution Improves Lab Efficiency and Accuracy - November 11, 2022 - DataJoint

PharmStars Announces Fall 2022 Startup Showcase Event

PharmStars Announces Fall 2022 Startup Showcase Event

PharmStars, the pharma-focused accelerator for digital health startups, announces that its Fall 2022 Showcase Event will begin on November 8, 2022. The Showcase is the culmination of a 10-week startup accelerator program. At the Showcase Event, startups will make formal presentations to and meet... - November 08, 2022 - PharmStars

Biomed Industries, Inc. (“Biomed”) Today Announced the Closing of Its Merger with MedAware Systems, Inc., (“MedAware”)

Biomed Industries, Inc. (“Biomed”) today announced the closing of its merger with MedAware Systems, Inc., (“MedAware”), in which all issued and outstanding common shares of capital stock of MedAware will be exchanged for common stock of Biomed at a ratio of 5.33 shares of MedAware for 1 new common share of Biomed. The transaction valued at an aggregate of $20 million, to be paid by 2,259,170 common shares of Biomed. At present, Biomed has approximately 76,354,075 common shares issued. - November 07, 2022 - Biomed Industries, Inc.

New Pivotal Data Demonstrates Clinical Feasibility of GeneFluidics’ Direct-from-Specimen AST in Clinical Settings

New Pivotal Data Demonstrates Clinical Feasibility of GeneFluidics’ Direct-from-Specimen AST in Clinical Settings

GeneFluidics, Inc. is pleased to announce a joint publication with the Medical College of Wisconsin (MCW) that introduces rapid antimicrobial susceptibility testing (AST), which would represent a paradigm shift in the clinical management of microbial infections. The data from the MCW study have... - November 04, 2022 - GeneFluidics Inc.

Introducing Wholeview Direct: Delivering Addiction Treatment Directly Into the Homes of New Yorkers

Introducing Wholeview Direct: Delivering Addiction Treatment Directly Into the Homes of New Yorkers

Wholeview Direct, a new, fully virtual, outpatient addiction treatment program has begun to provide treatment throughout the State of New York. - November 01, 2022 - Wholeview Wellness

DistillerSR Launches New CuratorCR Capabilities to More Dynamically Manage and Reuse Evidence-Based Research

CuratorCR Knowledge Center Provides Alternative to Elsevier’s QUOSA Virtual Library as Its Sunset Date Looms. - October 31, 2022 - DistillerSR

UTECH® Products Expands Operations to Abu Dhabi, Totaling Eight International Offices

UTECH® Products Expands Operations to Abu Dhabi, Totaling Eight International Offices

UTECH® Products Inc., a medical and laboratory equipment and supplies company is pleased to announce expanding operations to Abu Dhabi, United Arab Emirates, making it its 8th office worldwide. UTECH is bringing its expansive offerings to the Middle East market as a global leader in medical... - October 25, 2022 - EndoSoft

ASTER Labs, Inc. Awarded SpaceWERX Orbital Prime Contract

ASTER Labs, Inc. has been awarded a STTR Phase I under the SpaceWERX Orbital Prime Program. - October 23, 2022 - ASTER Labs Inc.

Creative Diagnostics Introduces Fluorometric Neuraminidase Assay Service for High-Throughput Discovery

As an expert in the antiviral field providing solutions to assist virology and microbiology research, Creative Diagnostics recently introduced Fluorometric Neuraminidase Assay services to the global research community, suitable for functional detection of NI-resistant viruses in mixed virus... - October 23, 2022 - Creative Diagnostics

Biolexis Therapeutics Announces Launch of FIELDS, an AI/ML Drug Discovery Platform

Biolexis is the first company to combine a curated historical wet-lab database, including half-a-million targets of binding data points, with an automated AI/ML-augmented discovery platform. - October 14, 2022 - Biolexis Therapeutics Inc.

Huntington Study Group Enrolls First Participant for Its Observational Study to Test the Reliability of the Virtual Use of the Unified Huntington’s Disease Rating Scale

Huntington Study Group Enrolls First Participant for Its Observational Study to Test the Reliability of the Virtual Use of the Unified Huntington’s Disease Rating Scale

The Huntington Study Group (HSG), a world leader in conducting clinical trials for Huntington’s Disease (HD) for over 30 years, together with its Clinical Research Organization (“CRO”), the HSG Clinical Research, Inc., today announces the enrollment of the first participant of its... - October 12, 2022 - Huntington Study Group

Press Releases 101 - 150 of 474